Literature DB >> 33564067

DNA methylome profiling of circulating tumor cells in lung cancer at single base-pair resolution.

Lei Zhao1,2,3, Xiaohong Wu4, Junnian Zheng5,6, Dong Dong7,8.   

Abstract

DNA methylation plays a pivotal role in regulating cellular processes, and altered DNA methylation pattern is a general hallmark of cancer. However, DNA methylome in circulating tumor cells (CTCs) is still a mystery due to the lack of proper analytical techniques. We introduced an efficient workflow, LCM-µWGBS, which can efficiently profile the DNA methylation of microdissected CTC samples. LCM-µWGBS combines the laser capture microdissection (LCM)-based CTC capture method and whole-genome bisulfite sequencing in very small CTC population (µWGBS) to gain insight into the DNA methylation landscape of CTCs. We herein profiled the DNA methylome of CTCs from lung cancer patients. Deriving from a comprehensive analysis of CTC methylome, a unique "CTC DNA methylation signature" that is distinct from primary lung cancer tissues was identified. Further analysis showed that promoter hypermethylation of epithelial genes is a hallmark of stable epithelial-mesenchymal transition process. Moreover, it has been suggested that CTCs are endowed with a stemness-related feature during dissemination and metastasis. This work constitutes a unique DNA methylation analysis of CTCs at single base-pair resolution, which might facilitate to propose noninvasive CTC DNA methylation biomarkers contributing to clinical diagnosis.

Entities:  

Year:  2021        PMID: 33564067      PMCID: PMC7946637          DOI: 10.1038/s41388-021-01657-0

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

Review 1.  Circulating Tumor Cells in Breast Cancer Patients: A Balancing Act between Stemness, EMT Features and DNA Damage Responses.

Authors:  Benedikt Heitmeir; Miriam Deniz; Wolfgang Janni; Brigitte Rack; Fabienne Schochter; Lisa Wiesmüller
Journal:  Cancers (Basel)       Date:  2022-02-16       Impact factor: 6.639

2.  DNA Methylation Analysis in Plasma Cell-Free DNA and Paired CTCs of NSCLC Patients before and after Osimertinib Treatment.

Authors:  Aliki Ntzifa; Dora Londra; Theodoros Rampias; Athanasios Kotsakis; Vassilis Georgoulias; Evi Lianidou
Journal:  Cancers (Basel)       Date:  2021-11-27       Impact factor: 6.639

Review 3.  Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer-An Update.

Authors:  Joanna Kapeleris; Majid Ebrahimi Warkiani; Arutha Kulasinghe; Ian Vela; Liz Kenny; Rahul Ladwa; Kenneth O'Byrne; Chamindie Punyadeera
Journal:  Front Oncol       Date:  2022-03-15       Impact factor: 6.244

Review 4.  A narrative review of circulating tumor cells clusters: A key morphology of cancer cells in circulation promote hematogenous metastasis.

Authors:  Qiong Chen; Jueyao Zou; Yong He; Yanhong Pan; Gejun Yang; Han Zhao; Ying Huang; Yang Zhao; Aiyun Wang; Wenxing Chen; Yin Lu
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738

Review 5.  Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer.

Authors:  Peilong Li; Shibiao Liu; Lutao Du; Ghazal Mohseni; Yi Zhang; Chuanxin Wang
Journal:  Clin Epigenetics       Date:  2022-09-24       Impact factor: 7.259

Review 6.  Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring.

Authors:  Wen Li; Ji-Bin Liu; Li-Kun Hou; Fei Yu; Jie Zhang; Wei Wu; Xiao-Mei Tang; Feng Sun; Hai-Min Lu; Jing Deng; Jie Bai; Juan Li; Chun-Yan Wu; Qin-Lu Lin; Zhong-Wei Lv; Gao-Ren Wang; Geng-Xi Jiang; Yu-Shui Ma; Da Fu
Journal:  Mol Cancer       Date:  2022-01-20       Impact factor: 27.401

Review 7.  Methylation Markers in Cutaneous Melanoma: Unravelling the Potential Utility of Their Tracking by Liquid Biopsy.

Authors:  Valentina Aleotti; Cristina Catoni; Cristina Poggiana; Antonio Rosato; Antonella Facchinetti; Maria Chiara Scaini
Journal:  Cancers (Basel)       Date:  2021-12-10       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.